Abstract
Background: To examine outcomes and prognostic factors in a large prospectively collected database of patients treated with Gamma Knife (GK) radiosurgery for breast cancer metastases to the brain. Methods: All patients were treated with GK radiosurgery for brain metastases from breast cancer between 1993 and 2009. Overall survival time was calculated from the time of GK radiosurgery to the time of death from any cause. Kaplan-Meier analysis was applied to calculate overall median time to failure and clinical and radiologic features of the study population. Multivariate analysis was performed using Cox Proportional Hazards regression analysis to calculate relative risk for mortality. Results: Two hundred and ninety-two patients with were analyzed over a median follow-up of 8.53 months (reverse Kaplan-Meier follow-up of 66.81 months). The median overall survival for the entire cohort from the time of GK radiosurgery was 9.08 months (95% CI, 7.86-10.63 months). There was a significantly greater median overall survival in patients that had KPS > 70, age 65) and multiple lesions (> 3 lesions) were independent predictors of poor prognosis. The risk of mortality in patients with low KPS, multiple lesions, and older age (as defined above) was 300%, 80%, 50% greater than their counterparts, respectively. Conclusion: Patients with poor performance status and multiple brain metastases from breast cancer have worse outcomes and may be candidates for conservative management. Categories: Radiation Oncology, Neurosurgery
Highlights
Breast cancer is the most common malignancy diagnosed in women in the United States.How to cite this article Wolf A L, Redmond K J, Bortoletto P, et al (May 10, 2012) Gamma Knife Radiosurgery for Breast Cancer Metastases to the Brain: Outcomes and Prognostic Factors from a Large Prospectively Collected Database
All patients were treated with Gamma Knife (GK) radiosurgery for breast cancer brain metastases
Follow-up data and details of the administered radiotherapy was known for 257 patients, of which 210 (81.72%) patients were treated with GK
Summary
Breast cancer is the most common malignancy diagnosed in women in the United States.How to cite this article Wolf A L, Redmond K J, Bortoletto P, et al (May 10, 2012) Gamma Knife Radiosurgery for Breast Cancer Metastases to the Brain: Outcomes and Prognostic Factors from a Large Prospectively Collected Database. The rate of CNS metastases from breast cancer appears to be increasing [8,9,10], in part because improved systemic therapies are allowing patients to survive long enough to develop distant metastases, including to the brain. Many of these new targeted agents are large molecules which do not cross the blood-brain barrier and are, likely to be ineffective at controlling CNS disease. To examine outcomes and prognostic factors in a large prospectively collected database of patients treated with Gamma Knife (GK) radiosurgery for breast cancer metastases to the brain
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
